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Abstract: Purpose 
British Thoracic Society (BTS) guidelines advocate using FDG PET-CT with 
the Herder model to estimate malignancy risk in solitary pulmonary 
nodules (SPNs). Qualitative and semi-quantitative assessment of SPN 
uptake is based upon analysis of Ordered Subset Expected Maximisation 
(OSEM) PET images. Our aim was to assess the effect of Bayesian Penalised 
Likelihood (BPL) PET reconstruction on the assessment of SPN FDG uptake 
and estimation of malignancy risk (Herder score). 
Methods 
Subjects with SPNs who underwent FDG PET-CT between 2014-2017, with 
histological confirmation of malignancy or histological/imaging follow-up 
confirmation of benignity were included. Two blinded readers 
independently classified SPN uptake on both OSEM and BPL (BTS score; 1 = 
none; 2 = ≤ mediastinal blood pool (MBP); 3 = >MBP but ≤ 2x liver; 4 = 
>2x liver), with resultant calculation of the Herder score (%) for both 
reconstructions. 
Results 
97 subjects with 75 (77%) malignant SPNs were included. BPL increased the 
BTS score in 25 (26%) SPNs; 9 SPNs (7 malignant) increased from BTS score 
2 to 3, 16 (13 malignant) from BTS score 3 to 4, with a mean Herder score 
increase of 18+/-22%. The mean Herder score for all SPNs with BPL was 
higher than OSEM (73+/-29 vs 68+/-32%, p=0.001). There was no difference 
in Herder model diagnostic performance between BPL and OSEM, with similar 
areas under the curve (0.84 vs 0.83, p=0.39). 
Conclusion 
BPL increases the Herder score in 26% of SPNs compared to OSEM but does 
not alter the diagnostic performance of the Herder model. 
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The effect of a novel Bayesian Penalised Likelihood PET reconstruction algorithm on the assessment of 
malignancy risk in solitary pulmonary nodules according to the British Thoracic Society guidelines 
Abstract 
Purpose 
British Thoracic Society (BTS) guidelines advocate using FDG PET-CT with the Herder model to estimate 
malignancy risk in solitary pulmonary nodules (SPNs). Qualitative and semi-quantitative assessment of SPN 
uptake is based upon analysis of Ordered Subset Expected Maximisation (OSEM) PET images. Our aim was 
to assess the effect of Bayesian Penalised Likelihood (BPL) PET reconstruction on the assessment of SPN 
FDG uptake and estimation of malignancy risk (Herder score). 
Methods 
Subjects with SPNs who underwent FDG PET-CT between 2014-2017, with histological confirmation of 
malignancy or histological/imaging follow-up confirmation of benignity were included. Two blinded 
readers independently classified SPN uptake on both OSEM and BPL (BTS score; 1 = none; 2 = ≤ mediastinal 
blood pool (MBP); 3 = >MBP but ≤ 2x liver; 4 = >2x liver), with resultant calculation of the Herder score (%) 
for both reconstructions. 
Results 
97 subjects with 75 (77%) malignant SPNs were included. BPL increased the BTS score in 25 (26%) SPNs; 9 
SPNs (7 malignant) increased from BTS score 2 to 3, 16 (13 malignant) from BTS score 3 to 4, with a mean 
Herder score increase of 1822%. The mean Herder score for all SPNs with BPL was higher than OSEM 
(7329 vs 6832%, p=0.001). There was no difference in Herder model diagnostic performance between 
BPL and OSEM, with similar areas under the curve (0.84 vs 0.83, p=0.39). 
Conclusion 
BPL increases the Herder score in 26% of SPNs compared to OSEM but does not alter the diagnostic 
performance of the Herder model. 
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Abbreviations 
Area under the curve (AUC) 
BPL= Bayesian Penalised Likelihood  
BTS= British Thoracic Society 
CT= Computed tomography 
FDG= 2-deoxy-2-[18F]fluoro-D-glucose 
ICC= Intra-class correlation 
MBP=Mediastinal blood pool 
OSEM=Ordered Subset Expected Maximisation 
PET= Positron emission tomography 
PSF= Point spread function  
ROC= Receiver operating characteristic 
SPN= Solitary pulmonary nodule 
SUV= Standardised uptake value 
 
 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
Introduction: 
Recent guidance issued by the British Thoracic Society (BTS) in 2015 [1] on the investigation and 
management of solitary pulmonary nodules (SPNs) advocates the use of clinico-radiological risk prediction 
models to guide clinical decision making for patients who have a SPN identified and confirmed on 
computed tomography (CT) imaging.  
Following an initial CT scan, an estimate of malignancy risk (< 10% or > 10%) is made using the Brock model 
[2], which encompasses findings on the CT scan (nodule size, type, location, count, spiculation, 
emphysema) along with clinical parameters (age, gender, family history of lung cancer). Patients with a 
greater than 10% risk of malignancy following their CT scan are recommended to undergo a 2-deoxy-2-
[18F]fluoro-D-glucose (FDG) positron emission tomography (PET)-CT scan for further risk stratification 
(<10%, 10-70% or >70% risk of malignancy), using the Herder model [3], which incorporates the degree of 
FDG uptake within a SPN, along with other clinico-radiological parameters (age, smoking status, history of 
extra-thoracic cancer, nodule size, location and spiculation). The incorporation of FDG uptake adds 
incremental benefit to diagnostic accuracy, increasing the area under the receiver operating characteristic 
(ROC) curve from 0.79 to 0.92 [3]. 
The Herder model, an accurate model incorporating PET for predicting malignancy in SPNs, has been 
validated in a UK population [4]. Its application is dependent on the accurate classification of FDG uptake in 
a SPN using qualitative assessment with an ordinal scale as follows; absent, faint, moderate, or intense. 
Herder et al. [3] did not provide detail regarding the definition of these levels of FDG uptake, although 
other studies have [5,6]. The BTS guideline development group adapted and derived a 4-point scale based 
on the above, to enable use with the Herder model (Table 1, Figure 1). 
Importantly, the degree of FDG uptake within SPNs is based upon analysis of PET images reconstructed 
using a standard PET reconstruction algorithm, Ordered Subset Expected Maximisation (OSEM). OSEM is 
an iterative reconstruction algorithm, with each successive iteration producing an image estimate closer to 
the true image, i.e. convergence. However, with each iteration, image noise increases and eventually 
reaches unacceptable levels whereby noise dominates. For this reason, OSEM is terminated after a set 
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number of iterations resulting in an underconverged image with quantification underestimation and 
resultant underestimation of standardised uptake values (SUVs) [7,8]. 
In recent years, novel PET reconstruction algorithms have been introduced to improve image quality 
through increasing signal-to-noise ratio. GE Healthcare have introduced a (Bayesian Penalised Likelihood) 
BPL iterative PET reconstruction algorithm, Q.Clear, which is available on modern GE Healthcare PET-CT 
scanners [9]. This reconstruction permits an increased number of iterations without an accompanying 
increase in noise due to the use of a penalty function, which acts as a noise suppressor, with the level of 
penalisation controlled by the penalisation factor beta, set by the user. The Q.Clear algorithm also includes 
point spread function (PSF) modelling. Studies have shown that BPL increases the apparent level of FDG 
uptake particularly in small lesions compared to OSEM [10-12]. This may potentially have a significant 
impact on the classification of FDG uptake within SPNs according to the BTS guidelines by increasing FDG 
uptake within a SPN to a greater degree than that of reference soft tissues, e.g. mediastinal blood pool 
(MBP), with resultant increases in the estimated risk of malignancy generated by the Herder model. The 
aim of this study is to investigate the effect of BPL, in comparison with OSEM, on the qualitative 
assessment of FDG uptake and resultant estimation of malignancy risk (Herder score) in SPNs assessed 
using the Herder model according to the current BTS guidelines. 
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Methods: 
Inclusion criteria 
Patients who underwent FDG PET-CT assessment of their SPN between January 2014-December 2017 were 
identified through institutional databases. 
Eligible patients fulfilled the following criteria: 
 FDG PET-CT examination performed on a GE 710 PET-CT system (GE Healthcare, Chicago, IL, USA) 
with assessable OSEM and BPL PET reconstructions. 
 SPNs measuring ≥ 5mm and ≤ 30mm in size. 
 Histological confirmation obtained either via percutaneous biopsy or surgical resection for all 
malignant nodules. 
 Histological confirmation, unchanged morphological appearances on CT follow-up (either by mean 
diameter for a minimum of 2 years, or by volumetric analysis for a minimum of 1 year) or resolution 
on follow-up imaging, for all benign nodules. 
An institutional board review approval was obtained for this retrospective analysis. 
FDG PET-CT imaging protocol 
All FDG PET-CT examinations were performed on one of two institutional GE 710 PET-CT systems. Patients 
were fasted for a minimum of 6 hours. A standard PET acquisition from skull base to upper thighs was 
acquired post-injection of 350MBq (±10%) of FDG with an axial field view of 15.7cm and an 11 slice overlap 
at 3 minutes per bed position. The mean tracer uptake time was 84  10 minutes (range 59-99 minutes). 
Non-attenuation corrected and attenuation corrected datasets were reconstructed. The low-dose 
unenhanced CT component was performed with patients maintaining normal shallow respiration, using a 
standardised protocol with the following settings: 140kV, pitch 1.375, 40mm beam collimation in the z-axis 
corresponding with the detector bank length (64 x 0.625 mm) with an effective slice collimation of 0.625 
mm, 0.5s rotation time, Auto mA (15-100mA, noise index 40). CT images were reconstructed with a slice 
thickness of 2.5mm. 
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PET reconstructions 
The standard clinical PET reconstruction was a Time of Flight OSEM reconstruction using 2 iterations, 24 
subsets and a 6.4mm Gaussian filter (VPFX, GE Healthcare). The archived raw data sinograms were 
retrospectively reconstructed using the novel BPL algorithm (Q.clear, GE Healthcare) with the established 
penalisation factor (beta) of 400, which has been identified to be the optimal penalty factor for FDG PET-CT 
imaging in oncology from previous studies [10-13]. PET images were reconstructed with a slice thickness of 
3.27mm and pixel size of 4.7mm. 
FDG PET-CT imaging review 
Image analysis was undertaken independently by a PET-CT fellow (DJM) and a consultant radionuclide 
radiologist (MS) with 2 and 7 years of experience in PET-CT reporting, respectively. Qualitative and semi-
quantitative analysis was performed on both PET reconstructions by both readers in a random order, 
blinded to the clinical information. Qualitative assessment of FDG uptake within SPNs was assigned a score 
according to the BTS score (Table 1, Figure 1). Although not explicitly mandated by Herder et al. [3] or BTS 
guidelines [1], semi-quantitative measures of FDG uptake, i.e. SUVmax, were used to help confirm the 
qualitative assessment and classification of FDG uptake in SPNs using the BTS scale. A freehand ROI was 
outlined in the arch of the aorta, careful to avoid the aortic walls, to define SUVmax MBP, whilst a large 
freehand ROI was outlined in the right lobe of the liver to define SUVmax hepatic activity, ignoring any 
voxels that contained spuriously elevated SUVmax values. We chose to measure MBP and hepatic SUVmax, as 
SUVmax is easily available, has good inter-reader reproducibility, and is relatively unaffected by partial 
volume averaging [14], and is recommended in the lymphoma literature as standard methodology 
regarding the Deauville criteria [15] . Scans with disagreement in BTS score between the two readers had 
consensus reads for both reconstructions. Once FDG uptake in all SPNs was classified, the estimated risk of 
malignancy was calculated for each SPN using the Herder model [3,16] for both PET reconstructions, as 
follows: 
Herder model = 1/(1 + e-x), 
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where x = -4.739 + 3.691 (% probability by the model of Swensen et al [17] ) + 2.322 (BTS score 2) + 4.617 
(BTS score 3) + 4.771 (BTS score 4); e is the base of natural logarithms; the level of nodule FDG uptake (BTS 
score) is denoted as 1 for present and 0 for absent. The Swenson model is as follows:  
Swensen model = 1/(1 + e-x), 
where x = -6.8272 + 0.0391 (age in years) + 0.7917 (cigarettes) + 1.3388 (cancer history) + 0.1274 
(diameter) + 1.0407 (spiculation) + 0.7838 (upper lobe); cigarettes is 1 if current/former smoker, otherwise 
0; cancer history is 1 if the patient has a history of extra-thoracic cancer; spiculation is 1 if the nodule is 
spiculated and upper lobe is 1 if the nodule has an upper lobe location. 
Statistical analysis 
Continuous variables are presented as mean ± standard deviation (SD). Categorical variables are presented 
as frequencies and percentages. Group comparison of continuous variables was performed using the 
Student’s t-test. Group comparisons of categorical variables were performed using the Wilcoxon matched- 
pairs test. A value of P <0.05 was considered significant. Inter-observer agreement for each PET 
reconstruction was assessed as follows. Firstly, the agreement between the categorised BTS scores was 
examined. Due to the ordinal nature of these categories, the weighted kappa method was used to assess 
agreement as follows: 0.81-1.00= very good agreement;  0.61- 0.80=good agreement, 0.41-0.60 =moderate 
agreement; 0.21- 0.4= fair agreement [18] . Secondly, the agreement between observers for the 
continuous Herder scores was examined using the intra-class coefficient (ICC) method. Bootstrapping 
methods were used to calculate a confidence interval for the difference in the level of agreement between 
the two PET reconstructions. For each PET reconstruction, the diagnostic performance of the continuous 
Herder score was determined by calculating the area under the ROC curve (AUC) [19]. The AUCs from the 
two PET reconstructions were compared using methods of comparing correlated ROC curves [20]. ROC 
curves were also generated for SPN SUVmax for each PET reconstruction using the averaged SPN SUVmax 
between the two readers. The ROC curve results were analysed to determine the sensitivity, specificity, 
positive and negative predictive values for a series of pre-defined Herder score cut-off points (0.1, 0.5 and 
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0.7), and to determine the optimum SPN SUVmax cut-off value. Confidence intervals were calculated using 
the exact binomial method. 
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Results 
 
Clinical and nodule characteristics (Table 2) 
Ninety-seven patients (47 female, 50 male, mean age 69  10 years) with 97 SPNs met the inclusion 
criteria. Of the 97 SPNs, 75 (77%) were malignant, and 22 (23%) benign. Malignant SPNs were 
predominantly non-small cell lung cancers (n= 67, 89%), with extra-thoracic metastasis (n=7, 9%) and small 
cell lung cancer (n=1, 1%) comprising the remainder. Benign aetiologies included infection, mycobacterial 
granulomata, granulomatous disease and intrapulmonary lymph nodes. The mean SPN size was 16  6 mm 
(range 5-29 mm), with 20 SPNs (21%) measuring  10mm in size. Malignant SPNs were significantly larger 
than benign SPNs (17.8  5.5 mm vs. 11.4  5.3 mm, p=0.0001), and were more likely to be spiculated (49 
vs. 5, p=0.0005). 
BTS nodule uptake score 
There was a significant difference in FDG uptake in SPNs classified using the BTS score, between the two 
PET reconstruction methods, with significantly higher BTS scores observed with BPL compared to OSEM 
(Figure 2, p<0.001). 84% of SPNs showed BTS 3 or 4 uptake on BPL, compared to 75% for OSEM. There was 
concordance in BTS score between the two PET reconstructions in 74% of SPNs (n=72) (Figure 3); BTS score 
1 = 5 SPNs, BTS score 2 = 10 SPNs, BTS score 3 = 26 SPNs, BTS score 4 = 31 SPNs. BPL increased the BTS 
score in 25 (26%) SPNs (20 malignant, 5 benign) (Figure 4); differences in BTS score were only by a single 
category with 9 SPNs (7 malignant) increasing from BTS score 2 to 3, and 16 (13 malignant) increasing from 
BTS score 3 to 4 (Figure 2). No SPN was categorised as a higher BTS score using OSEM. There was no 
disagreement between BPL and OSEM in the categorisation of BTS score 1 uptake. The mean diameter of 
the 25 SPNs that demonstrated an increase in BTS score with BPL was 13.8  3.9mm (range 8-24mm), 
significantly smaller than the mean diameter of 17.3  6.4mm (range 5-29mm) in the remainder of the 
SPNs that were unchanged (p=0.015).  
Herder score (Table 3). 
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Commensurate with the overall increase in the level of SPN FDG uptake associated with BPL, the overall 
mean Herder score was higher for BPL compared to OSEM (73  29% vs. 68  32%, p=0.001). The Herder 
score for malignant SPNs was higher for BPL than OSEM (83  19% vs. 78  25%, p=0.004), but not for 
benign SPNs (42  35% vs. 37 34%, p=0.07). For the 9 SPNs that increased from a BTS score 2 to 3, the 
mean Herder score increase was 48  3%, whilst for the 16 SPNs increasing from a BTS score 3 to 4, the 
mean Herder score increase was only 2  1%. Adenocarcinomas comprised 57% (n=43) of malignant SPNs 
and were the only histological subtype to demonstrate a significantly higher Herder score on BPL 
compared to OSEM images (84  16 % vs. 76  27 %, p=0.005); these results are summarised in Table 3. 
Nodule SUVmax (Table 3). 
Mean nodule SUVmax was significantly higher on the BPL images compared to OSEM for the overall cohort 
(7  5.2 g/ml vs 4.9  3.5 g/ml respectively, p=0.001), for malignant nodules (8.3  5.1 g/ml vs 5.8  3.5 
g/ml respectively, P=0.0004), but not for benign nodules (2.4  1.9 g/ml vs 1.8  1.3 g/ml respectively, 
p=0.07). There was no significant difference between the two PET reconstructions for measurement of 
mean MBP SUVmax, or mean liver SUVmax. 
Inter-observer agreement 
 
The inter-observer agreement using the BTS score was very good for both BPL and OSEM, with weighted 
kappas of 0.89 (95% CI: 0.74, 1.0) and 0.85 (95% CI: 0.71, 0.99), respectively. There was also very good 
inter-observer agreement using the continuous Herder score for both BPL and OSEM, with an ICC value of 
0.98 (95% CI: 0.97, 0.99) for BPL and 0.93 (95% CI: 0.90, 0.95) for OSEM. 
Diagnostic performance  
The diagnostic performance of the continuous Herder score (Figure 5a) revealed a good performance for 
both methods, with an AUC of 0.84 for BPL (95% CI: 0.75, 0.93), and 0.83 for OSEM (95% CI 0.74, 0.92) with 
no statistically significant difference (p=0.39). Using a Herder score cut-off of 10%, as proposed by the BTS 
guidelines, resulted in similar sensitivity and specificity for both techniques (Table 4). A Herder score of 
50% was more sensitive for BPL than OSEM, but less specific, and a cut-off of 70% yielded similar results 
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between the two methods. The diagnostic performance of SPN SUVmax (Figure 5b) for predicting 
malignancy, using each PET reconstruction, revealed a good performance of each method, with an AUC of 
0.87 for BPL (95% CI: 0.79, 0.94) and 0.88 for OSEM (95% CI: 0.81, 0.96), with no statistically significant 
difference between the two PET reconstructions (p=0.23). There was no statistically significant difference 
between the diagnostic performance of the Herder score and nodule SUVmax for either OSEM or BPL 
(p=0.09 and 0.35 respectively). The optimum SPN SUVmax cut-off value for BPL was 2.8g/ml (sensitivity 
0.87, specificity 0.68, PPV 0.9, NPV 0.6), and for OSEM 2.9g/ml (sensitivity 0.78, specificity 0.82, PPV 0.94, 
NPV 0.53).  
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Discussion 
BPL PET reconstruction increased the BTS score by a single category in comparison with OSEM, in 25 (26%) 
SPNs (20 malignant, 5 benign). SPNs whose BTS score increased with BPL were significantly smaller than 
those that remained unchanged (mean SPN diameter 13.8mm vs. 17.3mm respectively). Both Teoh et al. 
[11] and Howard et al. [21] found the greatest increase in SUVmax  was in smaller SPNs, particularly those in 
the 8-15mm range. 
BPL enables effective convergence of the image through an increased number of iterations by application 
of a penalisation factor to suppress image noise [13], which improves quantification and increases SUVmax, 
particularly in smaller lesions [22]. However, due to PSF modelling in Q.clear, the likelihood of artefacts 
increases [22]. This phenomenon, known as a Gibb’s artefact, is an artefactual increase in uptake at 
opposite edges of lesions, which in smaller lesions get closer together and overlap at a critical diameter, 
resulting in an artificial overestimation of intensity of uptake in the centre of the lesion. Yamaguchi et al. 
[23] showed that although BPL suppresses such artefacts, overestimation of uptake continues in smaller 
lesions, to a greater degree than OSEM with PSF modelling, resulting in concern that incorrect diagnoses 
based on SUVs might increase, particularly with lesions ~10mm. 
Although the increase in BTS score with BPL translated into an overall significant increase in the Herder 
score, this did not result in a change in diagnostic accuracy (0.84) compared to OSEM (0.83). Reviewing the 
25 SPNs that increased their BTS score with BPL; 16 increased from BTS score 3 to BTS score 4. This results 
in only a small change in the weighting factor, associated with level of FDG uptake, in the Herder model 
equation [3], resulting in an average final increase in the Herder score of only 2%. In practice, this is 
unlikely to result in management change, as nodules with BTS score 3 are already likely to be considered 
high risk for malignancy, given that BTS guidance advocates further investigation for any SPN with a Herder 
score of >10% [1]. The 9 SPNs that increased from BTS score 2 to BTS score 3 with BPL did result in a 
significant increase in the Herder score of 48%, due to an higher weighting factor in the Herder model 
equation [3]. A near 50% increase in Herder score has the potential to change management, resulting in 
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more aggressive and invasive management of SPNs, i.e. excision or non-surgical management (+/- image 
guided biopsy). The overall increase in Herder scores with BPL across the cohort explains the higher 
sensitivities compared to OSEM using the Herder score cut-offs of 0.5 and 0.7. The BTS guidelines propose 
a Herder score cut-off of 10%, above which further investigation or biopsy is recommended [1], and both 
OSEM and BPL demonstrated similar high sensitivities  and low specificities at this cut-off of 0.99 and 0.18 
respectively. Reassuringly, there was complete agreement between the two methods in determining BTS 
score 1. Distinguishing between BTS 2 and BTS 3 score in metabolically active SPNs is the most important 
PET-related factor determining the final Herder score. 
There was very good inter-observer agreement using the BTS scale. Herder et al. classified nodule uptake 
into faint, mild, moderate and intense, but did not define these cut-offs [3]. Al-Ameri et al. assigned SUVmax 
cut-offs to help classification; no uptake; faint uptake (SUVmax  2.5g/ml); moderate uptake (SUVmax 2.6-
10g/ml) intense uptake (SUVmax  10g/ml) [4]. Assigning strict SUVmax cut-off values can be problematic, 
due to the myriad of factors that can affect SUVmax readings other than lesional metabolic activity, 
including blood glucose levels, radiotracer uptake time, scanner type and PET reconstruction algorithm [7]. 
Internal reference controls, i.e. MBP and hepatic uptake, can overcome some of these reproducibility 
issues and have been validated in other malignancies [24]. The 2015 BTS guidelines defined the uptake 
levels proposed by Herder et al. with reference to background lung and MBP uptake [1]. We incorporated 
SUVmax rather than SUVmean in these reference regions to help confirm the qualitative BTS scale 
classification because although SUVmean may be less influenced by image noise than SUVmax, its 
reproducibility is more dependent on standardising the location and size of the region of interest than 
SUVmax,, limiting consistency between readers[24]. 
In our cohort, we found slightly higher AUCs for the diagnostic performance of SPN SUVmax on both OSEM 
and BPL compared with the Herder model, although the differences were not significant. This may be 
explained by the high prevalence of malignancy in our cohort of 77% compared with that of 57.5% in that 
of Herder et al.[3]. A meta-analysis by Gould et al [25]comprising 1474 pulmonary lesions found that 
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semiquantitative analysis of FDG uptake provided no additional benefit to the diagnostic accuracy achieved 
through qualitative visual assessment.  
There are several advantages to the use of risk prediction models. Firstly, they enable an estimate of 
malignancy risk based upon several established clinical and imaging predictors of malignancy rather than 
sole reliance on a single imaging parameter, i.e. SPN FDG uptake. Secondly, the estimation of risk helps 
guide management strategies with the lowest risk favouring the least invasive approach, i.e. CT 
surveillance, and vice versa; such practice is supported by data from cost-effectiveness studies [26,27]. 
Finally, and perhaps most importantly, it facilitates shared decision making between clinicians and patients 
by helping interpret SPN malignancy risk in the clinical context of risk of potential complications associated 
with any proposed invasive procedure, such as image-guided biopsy. 
Our study has limitations. It is a single centre, retrospective study, with a large malignant cohort of SPNs. 
Identification of more benign SPNs, was difficult due to a malignant bias in local FDG PET-CT referral 
patterns, which reflects real world clinical practice. This malignant bias did not however impact our 
primary aim to investigate the effect of BPL on BTS scale classification and Herder score in SPNs 
undergoing FDG PET-CT assessment. Inclusion of small nodules, down to 5mm in size, are at the limits of 
the spatial resolution of PET for accurate characterisation. Histological validation was not available for all 
benign SPNs, but this again reflects real world practice, where stability on follow-up imaging obviates the 
need for histological sampling. We used a freehand ROI to measure SPN FDG uptake for BPL and OSEM 
images; this could potentially introduce operator error in drawing the ROI around the nodule, but this 
limitation is mitigated by our use of SUVmax, which has lower operator related variability compared with 
SUVmean [28]. There was heterogeneity in the tracer uptake time across the cohort, which also has the 
potential to affect FDG uptake in SPNs, although this effect is difficult to quantify. 
Conclusion 
Classification of FDG uptake in a SPN as either below (BTS score 2) or above that of the MBP (BTS score 3) 
is the most important PET-related factor when using the Herder model and can be undertaken with very 
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good interobserver agreement for both OSEM and BPL. BPL reconstruction did not affect the overall 
diagnostic performance of the Herder model in comparison with OSEM, but BPL did change the BTS score 
in 26% of nodules and significantly increased the Herder score compared to OSEM, particularly in nodules 
~13mm. Smaller nodules may show increased FDG uptake with BPL due to a better estimation of true 
uptake but also possibly due to false overestimation due to Gibb’s artefact. If using BPL to quantify FDG 
uptake in a SPN, we recommend having OSEM reconstruction available for simultaneous review. Studies 
with a larger cohort and a higher proportion of benign SPNs may help determine the optimum Herder 
score cut-off value to distinguish between benign and malignant SPNs using BPL reconstructed images. 
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Tables 
 
Table 1. The BTS scale for classification of FDG uptake in SPNs 
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Table 2. Basic patient and nodule characteristics 
 
Table 3. Mean Herder scores & nodule SUVmax for BPL and OSEM reconstructions 
OSEM= Ordered Subset Expected Maximisation; BPL=Bayesian Penalisation Likelihood; NSCLC=non-small 
cell lung cancer; NOS=not otherwise specified. 
 
Table 4. Comparison of diagnostic abilities of OSEM and BPL reconstructions using pre-defined Herder 
score cut-off points 
OSEM= Ordered Subset Expected Maximisation; BPL=Bayesian Penalisation Likelihood; PPV=positive 
predictive value; NPV=negative predictive value. 
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Figure Legend 
Figure 1. Sample OSEM PET images for the BTS score (SUV scale 0-6 g/ml) 
1A. BTS score 1=No uptake. Axial image showing uniform uptake in the lung parenchyma, with no 
increased uptake seen in the 10mm right upper lobe (RUL) nodule (not visible) 
1B. BTS score 2=Faint. Axial image showing faint FDG uptake in a 12mm right lower lobe (RLL) nodule 
(arrow). Nodule SUVmax= 1.4 g/ml; Mediastinal blood pool SUVmax=1.9 g/ml. 
1C. BTS score 3=Moderate. Axial image showing moderate FDG uptake in a 18mm left lower lobe (LLL) 
nodule (arrow). Nodule SUVmax= 2.6 g/ml; Mediastinal blood pool SUVmax=1.8 g/ml. 
1D. BTS score 4=Intense. Coronal image showing intense FDG uptake in a 22mm LLL nodule (arrow). 
Nodule SUVmax= 6.9 g/ml; Liver SUVmax=2.9 g/ml. 
 
Figure 2. Comparison of SPN FDG uptake levels (BTS score) between OSEM and BPL reconstructions. 
 
BTS=British Thoracic Society; OSEM= Ordered Subset Expected Maximisation; BPL=Bayesian Penalisation 
Likelihood 
 
Figure 3. Example of a SPN which showed the same level of uptake on both OSEM and BPL reconstructed 
PET images 
 
3A. Coronal CT image on lung windows showing a 13mm RUL nodule (arrow). 
3B. Coronal OSEM PET image showing faint FDG uptake in the RUL nodule (arrow); BTS score 2. Nodule 
SUVmax= 1.5 g/ml; Mediastinal blood pool SUVmax=2.0 g/ml (SUV scale 0-6 g/ml). 
3C. Coronal BPL PET image showing faint FDG uptake in the RUL nodule (arrow); BTS score 2. Nodule 
SUVmax= 1.6 g/ml; Mediastinal blood pool SUVmax=1.9 g/ml (SUV scale 0-6 g/ml). 
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Figure 4. Example of a nodule which showed increased uptake on BPL compared to OSEM PET 
reconstructed images  
 
4A. Axial CT image on lung windows showing an 8mm LUL nodule (arrow). 
4B. Axial OSEM PET image showing faint uptake in the LUL nodule (arrow); BTS score 2. Nodule SUVmax=0.9 
g/ml, mediastinal blood pool SUVmax=1.2 g/ml (SUV scale 0-6 g/ml). 
4C. Axial BPL PET image showing moderate uptake in the LUL nodule (arrow); BTS score 3. Nodule 
SUVmax=1.9 g/ml, mediastinal blood pool SUVmax=1.1 g/ml (SUV scale 0-6 g/ml). 
 
Figure 5 
 
Figure 5a ROC curves for the diagnostic performance of the Herder score for predicting malignancy in 
SPNs, using both BPL and OSEM PET reconstructions.  
OSEM= Ordered Subset Expected Maximisation; BPL=Bayesian Penalisation Likelihood 
 
Figure 5b. ROC curves for the diagnostic performance of SPN SUVmax for predicting malignancy using 
both BPL and OSEM PET reconstructions.  
OSEM= Ordered Subset Expected Maximisation; BPL=Bayesian Penalisation Likelihood 
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Table 1. The BTS ordinal scale for classification of FDG uptake in SPNs 
SPN 
uptake 
BTS score Definition of FDG uptake in SPN Definition of SPN SUVmax 
Absent 1  ≤ background lung tissue = background lung tissue SUVmax 
Faint 2 ≤ MBP > background lung tissue SUVmax but ≤ 
MBP SUVmax 
Moderate 3 > MBP > MBP SUVmax but ≤ 2 times hepatic 
SUVmax 
Intense 4 Markedly > MBP > 2 times hepatic SUVmax 
BTS= British Thoracic Society; FDG= 2-deoxy-2-[18F]fluoro-D-glucose; SPN= solitary 
pulmonary nodule; MBP= mediastinal blood pool; SUVmax = maximum standardised uptake 
value. 
 
Table 1
Table 2. Basic patient and nodule characteristics 
 
 
Patient 
demographics 
(n=97) 
Overall 
n  SD (%) 
Benign  
(n=22, 23%) 
Malignant 
(n=75, 77%) 
P value 
Mean Age (years) 69  10 70.9  9.4 67.1  14.8 0.25 
Female 47 (48%) 9 (41%) 38 (51%) 0.47 
Current/former 
smoker  
81 (84%) 16 (73%) 65 (87%) 0.19 
Previous 
malignancy 
27 (28%) 5 (23%) 22 (29%) 0.6 
Nodule characteristics   
Mean nodule 
diameter (mm) 
16  6 11.4  5.3 17.8  5.5 0.0001 
Upper lobe 51 (53%) 12 (55%) 39 (52%) 1 
Spiculated 54 (56%) 5 (23%) 49 (65%) 0.0005 
Table 2
Table 3. Mean Herder scores & nodule SUVmax for BPL and OSEM reconstructions 
Mean Herder scores (% risk malignancy) 
Grouping (n) OSEM (%  
SD) 
BPL (%  SD) P value 
Overall (97) 68  32 73  29 0.0011 
Malignant (75) 78  25 83  19 0.0039 
Benign (22) 37  34 42  35 0.07 
Malignant nodules (n, %) 
Adenocarcinoma (43, 57%) 76  27 84  16 0.005 
Squamous (15, 20%) 91  6 92  6 0.3 
Carcinoid (5, 7%) 66  13 68  13 0.2 
NSCLC, NOS (4, 5%) 82  10 82  10 1 
Small cell (1, 1%) 80 80 1 
Metastasis (7, 9%) 67  38 67  39 0.3 
Mean Nodule SUVmax OSEM (g/ml  
SD) 
BPL (g/ml SD) P value 
Overall (95) 4.9  3.5 7  5.2 0.001 
Malignant (75)  5.8  3.5 8.3  5.1 0.0004 
Benign (22) 1.8  1.3 2.4  1.9 0.2 
OSEM= Ordered Subset Expected Maximisation; BPL=Bayesian Penalisation Likelihood; 
NSCLC=non-small cell lung cancer; NOS=not otherwise specified. 
 
Table 3
Table 4. Comparison of diagnostic abilities of OSEM and BPL reconstructions using pre-
defined Herder score cut-off points 
Herder 
score (%) 
 
Statistic OSEM 
Estimate (95% CI) 
BPL 
Estimate (95% CI) 
10 Sensitivity 0.99 (0.93, 1.00) 0.99 (0.93, 1.00) 
 Specificity 0.18 (0.05, 0.40) 0.18 (0.05, 0.40) 
 PPV 0.80 (0.71, 0.88) 0.80 (0.71, 0.88) 
 NPV 0.80 (0.28, 1.00) 0.80 (0.28, 1.00) 
50 Sensitivity 0.87 (0.77, 0.93) 0.96 (0.89, 0.99) 
 Specificity 0.64 (0.41, 0.83) 0.55 (0.32, 0.76) 
 PPV 0.89 (0.80, 0.95) 0.88 (0.79, 0.94) 
 NPV 0.58 (0.37, 0.78) 0.80 (0.52, 0.96) 
70 Sensitivity 0.77 (0.66, 0.86) 0.83 (0.72, 0.90) 
 Specificity 0.68 (0.45, 0.86) 0.68 (0.45, 0.86) 
 Positive PV 0.89 (0.79, 0.96) 0.90 (0.80, 0.96) 
 NPV 0.47 (0.29, 0.65) 0.54 (0.34, 0.73) 
    
OSEM= Ordered Subset Expected Maximisation; BPL=Bayesian Penalisation Likelihood; 
PPV=positive predictive value; NPV=negative predictive value. 
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